InnoCare Pharma Tech
As of the edition of 20 October 2026, InnoCare Pharma Tech runs 14 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Active | 11 |
| Went quiet | 1 |
| Status not established | 2 |
| Total | 14 |
Where its trials are
- Cancer: 16 trials led
- Immune system: 16 trials led
- Blood and lymph: 14 trials led